Back

From suspicion to ATTR-CM diagnosis: How do we streamline?

17 May 2025 (12:35 - 12:45)
Organised by: Logo
Congress Presentation Part of: ATTRibutes of change: advances in treating and monitoring ATTR-CM Cardiomyopathies HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Pablo Garcia-Pavia

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Spain)

6 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor A. Ristic (Belgrade, RS)
Presentation thumbnail
Linking serum TTR to patient outcomes in ATTR-CM
Doctor L. Obici (Pavia, IT)
Presentation thumbnail
New therapies for ATTR-CM, new patient expectations
Professor M. Fontana (London, GB)
Presentation thumbnail
Practical insights from ATTR-CM patient cases
Professor C. Tschoepe (Berlin, DE)
Presentation thumbnail
Panel discussion and Q&A

Access the full session

Session thumbnail
ATTRibutes of change: advances in treating and monitoring ATTR-CM
Video

The Event

Event poster

Heart Failure 2025

17 May 2025 12:35 CET
You may be interested in
thumbnail
Congress Session
When to look for amyloidosis
18 May 2025
thumbnail
Congress Session
Clinical and real-world data in ATTR cardiomyopathy: reviewing their place in daily practice
19 May 2025
thumbnail
Congress Presentation
Prevalence and characteristics of transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy: final analysis of the TTRACK study
22 May 2023
thumbnail
Congress Presentation
Exploring ATTR cardiomyopathy: the journey to improved outcomes
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources